Article Information
History
- November 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Seyedeh M. Zekavat, BS*,1,2,3,
- Shu-Hong Lin, PhD*,4,
- Alexander G. Bick, MD PhD5,2,
- Aoxing Liu, PhD6,
- Kaavya Paruchuri, MD2,3,7,
- Md Mesbah Uddin, PhD2,3,
- Yixuan Ye, BS1,
- Zhaolong Yu, BS1,
- Xiaoxi Liu, PhD8,
- Yoichiro Kamatani, PhD8,
- James P. Pirruccello, MD2,3,7,
- Akhil Pampana, MS2,3,
- Po-Ru Loh, PhD2,7,
- Puja Kohli, MD MMSc10,11,
- Steven A. McCarroll, PhD12,13,
- Benjamin Neale, PhD12,14,
- Eric A. Engels, MD MPH4,
- Derek W. Brown, PhD4,
- Jordan W. Smoller, MD ScD12,15,16,
- Robert Green, MD MPH2,7,9,
- Elizabeth W. Karlson, MD MS7,17,
- Matthew Lebo, PhD18,19,
- Patrick T. Ellinor, MD PhD2,3,7,
- Scott T. Weiss, MD MS7,20,
- Mark J. Daly6,
- The Biobank Japan Project,
- FinnGen Consortium,
- Chikashi Terao, MD PhD8,21,22,
- Hongyu Zhao, PhD1,23,
- Benjamin L. Ebert, MD PhD2,24,25,
- COVID-19 Host Genetics Initiative,
- Andrea Ganna, PhD6,14,2,
- Mitchell J. Machiela, ScD MPH#,4,
- Giulio Genovese, PhD#,2,12,9 and
- Pradeep Natarajan, MD MMSc#,2,3,7,†
- 1Computational Biology & Bioinformatics Program, Yale University, New Haven, CT
- 2Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
- 3Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
- 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
- 5Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center
- 6Institute for Molecular Medicine Finland, Helsinki, Finland
- 7Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
- 8Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan
- 9Department of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
- 10Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA
- 11Vertex Pharmaceuticals, Boston, MA
- 12Stanley Center, Broad Institute of Harvard and MIT, Cambridge, MA
- 13Department of Genetics, Harvard Medical School, Boston, MA
- 14Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA
- 15Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
- 16Department of Psychiatry, Harvard Medical School, Boston, MA
- 17Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital, Boston, MA
- 18Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
- 19Laboratory for Molecular Medicine, Partners Healthcare, Cambridge, MA
- 20Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA
- 21Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan
- 22The Department of Applied Genetics, The School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
- 23Department of Biostatistics, Yale School of Public Health, New Haven, CT
- 24Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 25Howard Hughes Medical Institute, Boston, MA, USA
- ↵†Please address correspondence to: Pradeep Natarajan MD, MMSc, Massachusetts General Hospital, 185 Cambridge Street, CPZN 3.184, Boston, MA 02114, Office: 617-726-1843, Email: pnatarajan{at}mgh.harvard.edu, Twitter: @pnatarajanmd
Posted November 16, 2020.
Hematopoietic mosaic chromosomal alterations and risk for infection among 767,891 individuals without blood cancer
